Cohen Fred E
- SEC CIK
- 0001339358
In the past year, 1 open-market purchase filing worth $1.40M and no sales.
Current role at each company
- CDNA CareDx, Inc.Directoras of Jun 16, 2026
- NTLA Intellia Therapeutics, Inc.Directoras of Jun 10, 2026
- KYTX Kyverna Therapeutics, Inc.Directoras of May 29, 2026
- URGN UroGen Pharma Ltd.Directoras of Aug 8, 2024
- PGNY Progyny, Inc.Directoras of May 28, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $1.40M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$1.40M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Cohen Fred E as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NTLA Intellia Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 (view filing) | Jan 5 | 2 days | Cohen Fred EDirector | PPurchase | +150.0K | $9.35 | +$1.40M | +261.1%207.5K after |